
Aegis Medicines Pvt Ltd
Provides hospital and medical care services.
Provides hospital and medical care services.
Pune, Maharashtra, India
+91-XXXXXXXXXX
U99999PN1993PTC073083
073083
Private Limited Indian Non-Government Company
23 Jul 1993
16 Aug 2022
31 Mar 2022
Unlisted
Roc Pune
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ayub Syed ![]() | Director | 23-Jul-1993 | Current |
Ayesha Syed ![]() | Director | 23-Jul-1993 | Current |
Aegis Medicines Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 518.47% decrease in profit. The company's net worth observed a substantial decline by a decrease of 705.54%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Aegis Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Ayub Syed and Ayesha Syed are mutual person
Ayub Syed is a mutual person
Ayub Syed and Ayesha Syed are mutual person
₹55.24 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
29 Jan 2013 | State Bank Of India | ₹32.02 Cr | Open |
31 Dec 2009 | State Bank Of India | ₹23.22 Cr | Open |
Unlock and access historical data on people associated with Aegis Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aegis Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aegis Medicines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Aegis Medicines Pvt Ltd last Annual general meeting of members was held on 16 Aug 2022 as per latest MCA records.
Aegis Medicines Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Pune.
A charge with State Bank Of India amounted to Rs. 32.02 Cr with Charge ID 10406822 was registered on 29 Jan 2013.
A charge with State Bank Of India of Rs. 23.22 Cr registered on 31 Dec 2009 with Charge ID 10199259 was modified on 17 Nov 2011.
A charge with State Bank Of India amounted to Rs. 23.22 Cr with Charge ID 10199259 was registered on 31 Dec 2009.
Ayub Gaffar Syed was appointed as a Director was appointed as a Director on 23 Jul 1993 & has been associated with this company since 31 years 9 months .
Aegis Medicines Pvt Ltd was incorporated on 23 Jul 1993.
The authorized share capital of Aegis Medicines Pvt Ltd is ₹ 10.00 Cr and paid-up capital is ₹ 6.24 Cr.
Currently 2 directors are associated with Aegis Medicines Pvt Ltd.
As per Ministry of Corporate Affairs (Mca), the registered address of Aegis Medicines Pvt Ltd is A-502 Kumar Gulmohar Cts No. 1436 Survey 70A/1/2/2B Wanowrie 4110 40. India, Pune, Maharashtra, 411040.
The corporate identification number (CIN) of Aegis Medicines Pvt Ltd is U99999PN1993PTC073083 and the company number is 073083 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Aegis Medicines Pvt Ltd has fallen by -100.00%.
The financial reports for the fiscal year 2022 indicates that The net worth of Aegis Medicines Pvt Ltd has experienced an downturn of -705.54%.
As per the financial statements for fiscal Year 2022, The total open charges for Aegis Medicines Pvt Ltd amount to ₹ 55.24 Cr.
The most recent Balance Sheet for Aegis Medicines Pvt Ltd was filed with the ROC on 31 Mar 2022.
Search company & director profiles for free and gain access to critical business data.
RS